This interactive forum discusses the latest in cell and gene therapy trends and their potential to impact the economy.
Blue Bell, Pennsylvania, March 19, 2021 – IPS-Integrated Project Services, LLC, a leading provider of engineering, procurement, construction management, and validation (EPCMV) services, announces its partnership with BioKansas to host the Community Forum – Cell & Gene Therapy on March 25th from 10:00 – 11:30 a.m. CST.
This Community Forum is open to all career levels and geographic regions. The event will share the latest cell and gene therapy trends and explain how growing Kansas City’s cell and gene industry will positively affect the regional economy.
Attendees will have the ability to connect directly with industry experts through interactive sessions. Presenters include Trent Armbrust, Sue Behrens, Todd Bradley, Ph.D., Heather Decker, Tom Piombino, Karthik Ramachandran, Ph.D., and Kimberly Young. Sessions will be moderated by Jason Collins, Sonia M. Hall, Ph.D., and Komal Hatti.
Event Agenda:
- 10:00-10:05 Event Introduction
- Presented by: Sonia M. Hall, Ph.D., President & CEO, BioKansas
- 10:05-10:20 Cell & Gene: Technology & Medicine
- Presented by: Tom Piombino, PE, Vice President, Design, IPS-Integrated Project Services, LLC
- 10:20-10:35 Impact of Cell and Gene Advancement on the Pharma Industry
-
- Presented by: Sue Behrens, George B and Joy Rathmann Professor in Bioprocessing and Director, Amgen Bioprocessing Center
- 10:35-10:50 Cell & Gene in the KC Region
- Presented by: Todd Bradley, Ph.D., Director of Immunogenomics, Genome Medicine Center and Children’s Mercy Research Institute
- 10:50-11:25 Cell & Gene as an Economic Driver
- Moderated by: Jason Collins, Director of Process Architecture, IPS-Integrated Project Services, LLC
- Panelists:
- Karthik Ramachandran, Ph.D., Chief Operating Officer and Co-Founder, Likarda
- Kimberly Young, President, KC Animal Health Corridor
- Trent Armbrust, Director of Strategy, Bioscience and Technology, Kansas Department of Commerce
- Heather Decker, Chief Technology Officer, Ronawk, LLC
- 11:25-11:28 Upcoming Pharma Event Preview
- 11:28-11:30 Closing Remarks
- Presented by: Komal Hatti, NCARB, MBA, LEED AP, Director, Process Architect, Associate, IPS-Integrated Project Services, LLC
“A concerted investment in cell and gene technology is vital for the Kansas City region, as it is quickly becoming one of the most dominant sectors of the pharmaceutical industry,” states Komal Hatti, IPS Director, Process Architect, and program coordinator and moderator.
Register for the event on the BioKansas website.
Download this full announcement here.
